See All Slides - tctmd.com

Slides

Presentation TCT 2018

The Methods for Translational Mitral/Tricuspid Valve Development

Presenter: Robert O. Bonow, John C Laschinger, Michael J. Mack

September 21, 2018

Presentation TCT 2018

Featured Lecture #2: Democratizing Clinical Excellence: Combining Digitized Patient Data and Guideline-Directed Best Practice

Presenter: Sanjeev Bhavnani, Issam D. Moussa, Lonny Reisman

September 21, 2018

Presentation TCT 2018

Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

Presenter: Jose Armando Mangione

September 21, 2018

Presentation TCT 2018

Debate Pro: TAVR for Moderate-Risk Patients: Ready for Prime Time!

Presenter: Gerardo Nau

September 21, 2018

Presentation TCT 2018

Case Presentation: Endograft for Aortoiliac Occlusive and Aneurysmal Disease

Presenter: Sahil A. Parikh, Virendra I Patel, Robert M. Bersin, Rahul S. Patel, Craig M. Walker

September 21, 2018

Presentation TCT 2018

Case Presentation: Complex Endograft FEVAR

Presenter: Sahil A. Parikh, Virendra I Patel, Robert M. Bersin, Rahul S. Patel, Craig M. Walker

September 21, 2018

Presentation TCT 2018

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

Presenter: Anibal A. Damonte

September 21, 2018

Presentation TCT 2018

Management of Endoleaks and New Data on Long-term Durability of Aortic Endografts

Presenter: Sahil A. Parikh, Virendra I Patel, Rahul S. Patel

September 21, 2018

Presentation TCT 2018

A Machine Learning Based Platform for Enhanced Patient Care and Virtual Communication: (M)Pirik

Presenter: Daniel O'Hair

September 21, 2018

Presentation TCT 2018

The Endpoints for Aortic Valve Development

Presenter: Jeroen J. Bax, Martin B. Leon, Ori Ben-Yehuda

September 21, 2018

Advertisement

Slides

The Methods for Translational Mitral/Tricuspid Valve Development

Featured Lecture #2: Democratizing Clinical Excellence: Combining Digitized Patient Data and Guideline-Directed Best Practice

Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

Debate Pro: TAVR for Moderate-Risk Patients: Ready for Prime Time!

Case Presentation: Endograft for Aortoiliac Occlusive and Aneurysmal Disease

Case Presentation: Complex Endograft FEVAR

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

Management of Endoleaks and New Data on Long-term Durability of Aortic Endografts

A Machine Learning Based Platform for Enhanced Patient Care and Virtual Communication: (M)Pirik

The Endpoints for Aortic Valve Development

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content